What is CatSci?
Founded in 2010 and headquartered in Cardiff, United Kingdom, CatSci operates as a medicine development and innovation partner. The company specializes in offering end-to-end non-clinical development of new therapeutics, positioning itself as a critical player in the pharmaceutical innovation ecosystem. Its services are designed to accelerate the journey of novel treatments from concept to preclinical stages, supporting biotech and pharmaceutical firms in their research and development endeavors.
How much funding has CatSci raised?
CatSci has raised a total of $5.9M across 1 funding round:
Other Financing Round
$5.9M
Other Financing Round (2022): $5.9M with participation from BOOST&Co
Key Investors in CatSci
BOOST&Co
BOOST&Co is a debt solutions provider for innovative European SMEs, offering tailored financing to support business development. Their independent approach and understanding of entrepreneurship make them a strategic backer for growth-stage companies.
What's next for CatSci?
With a recent major strategic investment and a history of substantial capital raises, CatSci is poised for accelerated growth. The enterprise-level funding suggests a strategic focus on scaling operations, expanding its service offerings, and potentially forging new partnerships within the pharmaceutical and biotechnology industries. This capital infusion will likely enable CatSci to enhance its capabilities in non-clinical drug development, further solidifying its role as a key innovation partner.
See full CatSci company page
